Monthly Archives: February 2018

http://www.lslog.com/pancreatic-stem-cell-discovery-opens-door-to-regenerative-treatments-for-diabetes/Pancreatic stem cell discovery opens door to regenerative treatments for diabetes

Pancreatic stem cell discovery opens door to regenerative treatments for diabetes

Pancreatic stem cell discovery opens door to regenerative treatments for diabetes Scientists at the Diabetes Research Institute have confirmed the existence of stem cells in the pancreas that can develop […]

http://www.lslog.com/turns-out-bayer-healthcares-faltering-even-before-monsanto-enters-the-fold/Turns out, Bayer HealthCare's faltering even before Monsanto enters the fold

Turns out, Bayer HealthCare's faltering even before Monsanto enters the fold

Turns out, Bayer HealthCare’s faltering even before Monsanto enters the fold Industry watchers were worried about neglect for Bayer’s healthcare division when the company chased down its megamerger with agrochemical […]

http://www.lslog.com/mallinckrodt-subpoenaed-again-over-sales-of-oxymorphone-in-growing-opioid-crisis/Mallinckrodt subpoenaed, again, over sales of oxymorphone in growing opioid crisis

Mallinckrodt subpoenaed, again, over sales of oxymorphone in growing opioid crisis

Mallinckrodt subpoenaed, again, over sales of oxymorphone in growing opioid crisis As opioid scrutiny intensifies around the country, Mallinckrodt has received another subpoena seeking information about its sales of the […]

http://www.lslog.com/ai-and-facial-diagnosis-company-fdna-sets-up-genomics-coalition/AI and facial diagnosis company FDNA sets up genomics coalition

AI and facial diagnosis company FDNA sets up genomics coalition

AI and facial diagnosis company FDNA sets up genomics coalition Boston biotech FDNA has teamed up with several research organizations to create a consortium that will try to apply artificial […]

http://www.lslog.com/1-year-later-rfk-jr-s-plan-for-vaccine-safety-commission-seems-stalled/1 year later, RFK Jr.'s plan for vaccine safety commission seems stalled

1 year later, RFK Jr.'s plan for vaccine safety commission seems stalled

1 year later, RFK Jr.’s plan for vaccine safety commission seems stalled RFK Jr. said there’s been “zero progress” on the controversial vaccine safety commission, according to The Guardian. Source: […]

http://www.lslog.com/as-diabetes-heats-up-lilly-looks-for-trulicity-edge-with-positive-sglt2-combo-data/As diabetes heats up, Lilly looks for Trulicity edge with positive SGLT2 combo data

As diabetes heats up, Lilly looks for Trulicity edge with positive SGLT2 combo data

As diabetes heats up, Lilly looks for Trulicity edge with positive SGLT2 combo data Eli Lilly has some formidable competition coming in the GLP-1 diabetes class, so it’s wasting no […]

http://www.lslog.com/generation-bio-raises-100m-for-druglike-gene-therapy/Generation Bio raises $100M for ‘druglike’ gene therapy

Generation Bio raises $100M for ‘druglike’ gene therapy

Generation Bio raises 0M for ‘druglike’ gene therapy Gene therapy startup Generation Bio has lost no time raising the resources it needs to take its programs forward into the clinic, […]

http://www.lslog.com/dbv-climbs-as-messy-milk-allergy-data-open-door-to-phase-3/DBV climbs as messy milk allergy data open door to phase 3

DBV climbs as messy milk allergy data open door to phase 3

DBV climbs as messy milk allergy data open door to phase 3 DBV Technologies has posted results from a midphase trial of its milk allergy candidate Viaskin Milk. The study […]

http://www.lslog.com/new-ftc-rules-hurt-ma-prospects-for-hard-hit-generics-players/New FTC rules hurt M&A prospects for hard-hit generics players

New FTC rules hurt M&A prospects for hard-hit generics players

New FTC rules hurt M&A prospects for hard-hit generics players The generics sector has been looking to M&A as a way to combat the pricing pressure crushing top lines around […]

http://www.lslog.com/allergan-was-blasted-for-its-unusual-mohawk-patent-license-and-now-its-a-total-flop/Allergan was blasted for its unusual Mohawk patent license, and now it's a total flop

Allergan was blasted for its unusual Mohawk patent license, and now it's a total flop

Allergan was blasted for its unusual Mohawk patent license, and now it’s a total flop After months of criticism that even spilled into a judge’s opinion in a separate case, […]